ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » General Practice

Top General Practice Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSE GORIS M.D.

General Practice

36,788

$2.82M

973
761 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $68

MARK DASHEVSKIY D.O

General Practice

19,729

$1.21M

627
611 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $68

LAWRENCE LERNER MD

General Practice

19,037

$949K

397
383 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $68

NAYAN DAS MD

General Practice

19,026

$1.14M

389
336 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $68

SAMI RAPHAEL MD

General Practice

16,686

$852K

580
480 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $68

RONALD GROSS M.D.

General Practice

16,269

$816K

595
519 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $68

DEVENDRA SHARMA M.D.

General Practice

15,827

$1.13M

318
208 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $68

LARISA MALISOVA DO

General Practice

14,404

$950K

743
669 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $68

MITUL PATEL M.D.

General Practice

13,583

$633K

416
355 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $68

MAXIMO VALERO MD

General Practice

13,279

$725K

373
347 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $68

LOUIS PERALTE M.D.

General Practice

12,431

$933K

288
275 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $68

TARIQ WASEEM M.D.

General Practice

11,491

$594K

392
332 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $68

DAVID DUNN MD

General Practice

11,201

$548K

449
370 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $68

CEFERINO VILLA FUERTE MD

General Practice

11,150

$892K

218
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$80
Average prescription price

Avg: $68

JAHANGIR KOLEINI MD

General Practice

11,042

$669K

489
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $68

YDELFONSO DECOO MD

General Practice

11,030

$591K

283
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $68

ROBERT KORMENDI M.D.

General Practice

10,233

$616K

265
223 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $68

JOHN GLENN MD

General Practice

9,945

$825K

491
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $68

DONNA SEMINARA MD

General Practice

9,941

$602K

687
625 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $68

MOHAMMAD QURESHI MD

General Practice

8,809

$656K

141
90 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $68

DONALD SHERWOOD MD

General Practice

8,193

$722K

329
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $68

MICHAEL DAVIA M.D.

General Practice

7,931

$434K

231
201 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $68

JOHN MCCARTHY D.O.

General Practice

7,877

$497K

330
225 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $68

GOPIRAM PANSARI MD

General Practice

7,698

$344K

367
304 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 29%

$45
Average prescription price

Avg: $68

JACOB SUNG KEUM D.O.

General Practice

7,692

$668K

207
182 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 29%

$87
Average prescription price

Avg: $68

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank